末梢動脈疾患治療の世界市場：産業分析、規模、シェア、成長、動向、予測（2025年～2035年）

末梢動脈疾患治療市場：調査範囲

TMRの調査レポート「末梢動脈疾患治療の世界市場」は、2025年～2035年の予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019年～2035年の世界の末梢動脈疾患治療市場の収益と予測を提供します。また、2025年～2035年の世界の末梢動脈疾患治療市場のCAGR%も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、末梢動脈疾患治療市場を推察しました。

当レポートでは、世界の末梢動脈疾患治療市場の競合情勢について調査しています。世界の末梢動脈疾患治療市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の末梢動脈疾患治療市場における企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー： 世界市場

第4章 市場概要

• イントロダクション
• 概要
• 市場力学
• 世界の末梢動脈疾患治療市場の分析と予測（2020年～2035年）

第5章 主要洞察

• 主要地域/国における規制状況
• 市場動向
• ポーターのファイブフォース分析
• PESTEL分析
• エンドユーザーにとっての主要な購入指標
• ブランドと価格分析
• 治療アルゴリズム
• 主要な業界イベント

第6章 世界の市場分析と予測：薬剤タイプ別

• イントロダクションと定義
• 主な調査結果/進展
• 市場金額予測：薬剤タイプ別（2020年～2035年）
  • 抗血小板薬
  • コレステロール低下薬（スタチン）
  • 降圧薬
  • 血圧の薬
  • 血管拡張薬
  • その他
• 市場の魅力：薬剤タイプ別

第7章 世界の市場分析と予測：投与経路別

• イントロダクションと定義
• 主な調査結果/進展
• 市場金額予測：投与経路別（2020年～2035年）
  • 経口
  • 非経口
• 市場の魅力：投与経路別

第8章 世界の市場分析と予測：流通チャネル別

• イントロダクションと定義
• 主な調査結果/進展
• 市場金額予測：流通チャネル別（2020年～2035年）
  • 院内薬局
  • 小売薬局
  • オンライン薬局
• 市場の魅力：流通チャネル別

第9章 世界の市場分析と予測：地域別

• 主な調査結果
• 市場金額予測：地域別
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ
• 市場の魅力：地域別

第10章 北米の市場分析と予測

• 米国
• カナダ

第11章 欧州の市場分析と予測

• ドイツ
• 英国
• フランス
• イタリア
• スペイン
• その他欧州

第12章 アジア太平洋の市場分析と予測

• 中国
• 日本
• インド
• オーストラリアとニュージーランド
• その他アジア太平洋

第13章 ラテンアメリカの市場分析と予測

• ブラジル
• メキシコ
• その他ラテンアメリカ

第14章 中東・アフリカの市場分析と予測

• GCC諸国
• 南アフリカ
• その他中東・アフリカ

第15章 競合情勢

• 市場企業：競合マトリックス（企業階層別・規模別）
• 市場シェア分析：企業別（2024年）
• 企業プロファイル
  • Bayer AG
  • Pfizer Inc.
  • Eli Lilly and Company
  • Cipla
  • Lupin
  • Viatris Inc
  • Johnson & Johnson Services, Inc.
  • Sanofi
  • Novartis AG
  • Amgen Inc.
  • Aurobindo Pharma Limited
  • その他

List of Tables

• Table 01: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
• Table 02: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
• Table 03: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
• Table 04: Global Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Region, 2020-2035
• Table 05: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country, 2020-2035
• Table 06: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
• Table 07: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
• Table 08: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
• Table 09: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country/ Sub-region, 2020-2035
• Table 10: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
• Table 11: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
• Table 12: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
• Table 13: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
• Table 14: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
• Table 15: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
• Table 16: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
• Table 17: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
• Table 18: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
• Table 19: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
• Table 20: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
• Table 21: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020-2035
• Table 22: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Drug Type, 2020-2035
• Table 23: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
• Table 24: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

• Figure 01: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
• Figure 02: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
• Figure 03: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Antiplatelet Drugs, 2020-2035
• Figure 04: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Cholesterol-Lowering Drugs (Statins), 2020-2035
• Figure 05: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Anti-hypertensive Drugs, 2020-2035
• Figure 06: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Blood Pressure Medications, 2020-2035
• Figure 07: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Vasodilators, 2020-2035
• Figure 08: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Others, 2020-2035
• Figure 09: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
• Figure 10: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
• Figure 11: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Oral, 2020-2035
• Figure 12: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Parenteral, 2020-2035
• Figure 13: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
• Figure 14: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
• Figure 15: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Hospital Pharmacies, 2020-2035
• Figure 16: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
• Figure 17: Global Peripheral Arterial Disease Treatment Market Revenue (US$ Bn), by Others, 2020-2035
• Figure 18: Global Peripheral Arterial Disease Treatment Market Value Share Analysis, By Region, 2024 and 2035
• Figure 19: Global Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Region, 2025-2035
• Figure 20: North America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
• Figure 21: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country, 2024 and 2035
• Figure 22: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country, 2025-2035
• Figure 23: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
• Figure 24: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
• Figure 25: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
• Figure 26: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
• Figure 27: North America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
• Figure 28: North America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
• Figure 29: Europe - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
• Figure 30: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
• Figure 31: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
• Figure 32: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
• Figure 33: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
• Figure 34: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
• Figure 35: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
• Figure 36: Europe - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
• Figure 37: Europe - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
• Figure 38: Asia Pacific - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
• Figure 39: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
• Figure 40: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
• Figure 41: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
• Figure 42: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
• Figure 43: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
• Figure 44: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
• Figure 45: Asia Pacific - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
• Figure 46: Asia Pacific - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
• Figure 47: Latin America - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
• Figure 48: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
• Figure 49: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
• Figure 50: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
• Figure 51: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
• Figure 52: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
• Figure 53: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
• Figure 54: Latin America - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
• Figure 55: Latin America - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035
• Figure 56: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value (US$ Bn) Forecast, 2020-2035
• Figure 57: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
• Figure 58: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, by Country / Sub-region, 2025-2035
• Figure 59: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Drug Type, 2024 and 2035
• Figure 60: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Drug Type, 2025-2035
• Figure 61: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Route of Administration, 2024 and 2035
• Figure 62: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Route of Administration, 2025-2035
• Figure 63: Middle East & Africa - Peripheral Arterial Disease Treatment Market Value Share Analysis, By Distribution Channel, 2024 and 2035
• Figure 64: Middle East & Africa - Peripheral Arterial Disease Treatment Market Attractiveness Analysis, By Distribution Channel, 2025-2035

Peripheral Arterial Disease Treatment Market - Scope of Report

TMR's report on the global peripheral arterial disease treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global peripheral arterial disease treatment market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global peripheral arterial disease treatment market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the peripheral arterial disease treatment market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global peripheral arterial disease treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global peripheral arterial disease treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global peripheral arterial disease treatment market.

The report delves into the competitive landscape of the global peripheral arterial disease treatment market. Key players operating in the global peripheral arterial disease treatment market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global peripheral arterial disease treatment market profiled in this report.

Key Questions Answered in Global peripheral arterial disease treatment market Report:

• What is the sales/revenue generated by peripheral arterial disease treatment across all regions during the forecast period?
• What are the opportunities in the global peripheral arterial disease treatment market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Peripheral Arterial Disease Treatment Market - Research Objectives and Research Approach

The comprehensive report on the global peripheral arterial disease treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global peripheral arterial disease treatment market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global peripheral arterial disease treatment market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Peripheral Arterial Disease Treatment Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, 2020-2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Regulatory Landscape across Key Regions / Countries
• 5.2. Market Trends
• 5.3. PORTER's Five Forces Analysis
• 5.4. PESTEL Analysis
• 5.5. Key Purchase Metrics for End-users
• 5.6. Brand and Pricing Analysis
• 5.7. Treatment Algorithm
• 5.8. Key Industry Events

6. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Drug Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Drug Type, 2020-2035
  • 6.3.1. Antiplatelet Drugs
  • 6.3.2. Cholesterol-Lowering Drugs (Statins)
  • 6.3.3. Anti-hypertensive Drugs
  • 6.3.4. Blood Pressure Medications
  • 6.3.5. Vasodilators
  • 6.3.6. Others
• 6.4. Market Attractiveness By Drug Type

7. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Route of Administration

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Route of Administration, 2020-2035
  • 7.3.1. Oral
  • 7.3.2. Parenteral
• 7.4. Market Attractiveness By Route of Administration

8. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Distribution Channel

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Distribution Channel, 2020-2035
  • 8.3.1. Hospital Pharmacies
  • 8.3.2. Retail Pharmacies
  • 8.3.3. Online Pharmacies
• 8.4. Market Attractiveness By Distribution Channel

9. Global Peripheral Arterial Disease Treatment Market Analysis and Forecasts, By Region

• 9.1. Key Findings
• 9.2. Market Value Forecast By Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness By Region

10. North America Peripheral Arterial Disease Treatment Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast By Drug Type, 2020-2035
  • 10.2.1. Antiplatelet Drugs
  • 10.2.2. Cholesterol-Lowering Drugs (Statins)
  • 10.2.3. Anti-hypertensive Drugs
  • 10.2.4. Blood Pressure Medications
  • 10.2.5. Vasodilators
  • 10.2.6. Others
• 10.3. Market Value Forecast By Route of Administration, 2020-2035
  • 10.3.1. Oral
  • 10.3.2. Parenteral
• 10.4. Market Value Forecast By Distribution Channel, 2020-2035
  • 10.4.1. Hospital Pharmacies
  • 10.4.2. Retail Pharmacies
  • 10.4.3. Online Pharmacies
• 10.5. Market Value Forecast By Country, 2020-2035
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Drug Type
  • 10.6.2. By Route of Administration
  • 10.6.3. By Distribution Channel
  • 10.6.4. By Country

11. Europe Peripheral Arterial Disease Treatment Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Drug Type, 2020-2035
  • 11.2.1. Antiplatelet Drugs
  • 11.2.2. Cholesterol-Lowering Drugs (Statins)
  • 11.2.3. Anti-hypertensive Drugs
  • 11.2.4. Blood Pressure Medications
  • 11.2.5. Vasodilators
  • 11.2.6. Others
• 11.3. Market Value Forecast By Route of Administration, 2020-2035
  • 11.3.1. Oral
  • 11.3.2. Parenteral
• 11.4. Market Value Forecast By Distribution Channel, 2020-2035
  • 11.4.1. Hospital Pharmacies
  • 11.4.2. Retail Pharmacies
  • 11.4.3. Online Pharmacies
• 11.5. Market Value Forecast By Country/Sub-region, 2020-2035
  • 11.5.1. Germany
  • 11.5.2. U.K.
  • 11.5.3. France
  • 11.5.4. Italy
  • 11.5.5. Spain
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Drug Type
  • 11.6.2. By Route of Administration
  • 11.6.3. By Distribution Channel
  • 11.6.4. By Country/Sub-region

12. Asia Pacific Peripheral Arterial Disease Treatment Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Drug Type, 2020-2035
  • 12.2.1. Antiplatelet Drugs
  • 12.2.2. Cholesterol-Lowering Drugs (Statins)
  • 12.2.3. Anti-hypertensive Drugs
  • 12.2.4. Blood Pressure Medications
  • 12.2.5. Vasodilators
  • 12.2.6. Others
• 12.3. Market Value Forecast By Route of Administration, 2020-2035
  • 12.3.1. Oral
  • 12.3.2. Parenteral
• 12.4. Market Value Forecast By Distribution Channel, 2020-2035
  • 12.4.1. Hospital Pharmacies
  • 12.4.2. Retail Pharmacies
  • 12.4.3. Online Pharmacies
• 12.5. Market Value Forecast By Country/Sub-region, 2020-2035
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Drug Type
  • 12.6.2. By Route of Administration
  • 12.6.3. By Distribution Channel
  • 12.6.4. By Country/Sub-region

13. Latin America Peripheral Arterial Disease Treatment Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Drug Type, 2020-2035
  • 13.2.1. Antiplatelet Drugs
  • 13.2.2. Cholesterol-Lowering Drugs (Statins)
  • 13.2.3. Anti-hypertensive Drugs
  • 13.2.4. Blood Pressure Medications
  • 13.2.5. Vasodilators
  • 13.2.6. Others
• 13.3. Market Value Forecast By Route of Administration, 2020-2035
  • 13.3.1. Oral
  • 13.3.2. Parenteral
• 13.4. Market Value Forecast By Distribution Channel, 2020-2035
  • 13.4.1. Hospital Pharmacies
  • 13.4.2. Retail Pharmacies
  • 13.4.3. Online Pharmacies
• 13.5. Market Value Forecast By Country/Sub-region, 2020-2035
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Drug Type
  • 13.6.2. By Route of Administration
  • 13.6.3. By Distribution Channel
  • 13.6.4. By Country/Sub-region

14. Middle East & Africa Peripheral Arterial Disease Treatment Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Drug Type, 2020-2035
  • 14.2.1. Antiplatelet Drugs
  • 14.2.2. Cholesterol-Lowering Drugs (Statins)
  • 14.2.3. Anti-hypertensive Drugs
  • 14.2.4. Blood Pressure Medications
  • 14.2.5. Vasodilators
  • 14.2.6. Others
• 14.3. Market Value Forecast By Route of Administration, 2020-2035
  • 14.3.1. Oral
  • 14.3.2. Parenteral
• 14.4. Market Value Forecast By Distribution Channel, 2020-2035
  • 14.4.1. Hospital Pharmacies
  • 14.4.2. Retail Pharmacies
  • 14.4.3. Online Pharmacies
• 14.5. Market Value Forecast By Country/Sub-region, 2020-2035
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Drug Type
  • 14.6.2. By Route of Administration
  • 14.6.3. By Distribution Channel
  • 14.6.4. By Country/Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Market Share Analysis By Company (2024)
• 15.3. Company Profiles
  • 15.3.1. Bayer AG
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Financial Overview
    • 15.3.1.3. Product Portfolio
    • 15.3.1.4. Business Strategies
    • 15.3.1.5. Recent Developments
  • 15.3.2. Pfizer Inc.
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Financial Overview
    • 15.3.2.3. Product Portfolio
    • 15.3.2.4. Business Strategies
    • 15.3.2.5. Recent Developments
  • 15.3.3. Eli Lilly and Company
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Financial Overview
    • 15.3.3.3. Product Portfolio
    • 15.3.3.4. Business Strategies
    • 15.3.3.5. Recent Developments
  • 15.3.4. Cipla
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Financial Overview
    • 15.3.4.3. Product Portfolio
    • 15.3.4.4. Business Strategies
    • 15.3.4.5. Recent Developments
  • 15.3.5. Lupin
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Financial Overview
    • 15.3.5.3. Product Portfolio
    • 15.3.5.4. Business Strategies
    • 15.3.5.5. Recent Developments
  • 15.3.6. Viatris Inc
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Financial Overview
    • 15.3.6.3. Product Portfolio
    • 15.3.6.4. Business Strategies
    • 15.3.6.5. Recent Developments
  • 15.3.7. Johnson & Johnson Services, Inc.
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Financial Overview
    • 15.3.7.3. Product Portfolio
    • 15.3.7.4. Business Strategies
    • 15.3.7.5. Recent Developments
  • 15.3.8. Sanofi
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Financial Overview
    • 15.3.8.3. Product Portfolio
    • 15.3.8.4. Business Strategies
    • 15.3.8.5. Recent Developments
  • 15.3.9. Novartis AG
    • 15.3.9.1. Company Overview
    • 15.3.9.2. Financial Overview
    • 15.3.9.3. Product Portfolio
    • 15.3.9.4. Business Strategies
    • 15.3.9.5. Recent Developments
  • 15.3.10. Amgen Inc.
    • 15.3.10.1. Company Overview
    • 15.3.10.2. Financial Overview
    • 15.3.10.3. Product Portfolio
    • 15.3.10.4. Business Strategies
    • 15.3.10.5. Recent Developments
  • 15.3.11. Aurobindo Pharma Limited
    • 15.3.11.1. Company Overview
    • 15.3.11.2. Financial Overview
    • 15.3.11.3. Product Portfolio
    • 15.3.11.4. Business Strategies
    • 15.3.11.5. Recent Developments
  • 15.3.12. Other Prominent Players
    • 15.3.12.1. Company Overview
    • 15.3.12.2. Financial Overview
    • 15.3.12.3. Product Portfolio
    • 15.3.12.4. Business Strategies
    • 15.3.12.5. Recent Developments